Developing an Effective Vaccine for Herpes Simplex Virus – Drug Target Review

Read article - David Leib, chair and a professor of microbiology and immunology; Margaret Ackerman, a professor of engineering; Matthew Slein, Guarini; and Iara Backes, Guarini ’22, MED ’24, are featured in an article about their study into how antibodies function when fighting herpes simplex virus infections. “Another important aspect of the work that Matt and Iara have done is that we now have some really good monoclonal antibodies that we’ve made in the lab that could potentially be used directly as a medication to treat acute neonatal herpes infections, which are life-threatening to newborns,” Leib said.